Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2-Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14
| Autor: | Drexler, Beatrice *, Passweg, Jakob, Bigler, Martin *, Theocharides, Alexandre PA *, Cantoni, Nathan, Keller, Peter, Stuessi, Georg *, Rüfer, Axel *, Benz, Rudolf A., Favre, Geneviève, Tzankov, Alexandar *, Lundberg, Pontus *, Fuhrer, Andrea *, Biaggi, Christine *, Manz, Markus G, Bargetzi, Mario, Mendez-Ferrer, Simon, Skoda, Radek C. |
|---|---|
| Zdroj: | In Blood 2 December 2016 128(22):3108-3108 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|